Siemens Healthineers AG (SMMNY)
29.17
+0.09
(+0.31%)
USD |
OTCM |
May 23, 09:56
Siemens Healthineers Research and Development Expense (Annual): 1.995B for Sept. 30, 2023
Research and Development Expense (Annual) Chart
Historical Research and Development Expense (Annual) Data
| Date | Value |
|---|---|
| September 30, 2023 | 1.995B |
| September 30, 2022 | 1.937B |
| September 30, 2021 | 1.848B |
| September 30, 2020 | 1.504B |
| September 30, 2019 | 1.498B |
| Date | Value |
|---|---|
| September 30, 2018 | 1.525B |
| September 30, 2017 | 1.383B |
| September 30, 2016 | 1.272B |
| September 30, 2015 | 1.211B |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
1.498B
Minimum
2019
1.995B
Maximum
2023
1.756B
Average
1.848B
Median
2021
Research and Development Expense (Annual) Benchmarks
| Affimed NV | 102.80M |
| InflaRx NV | 44.41M |
| MorphoSys AG | 307.04M |
| BioNTech SE | 1.930B |
| Immatics NV | 128.47M |